Monday, September 14, 2026

H&M’s Collaboration with Korean Designer Brand Rokh Sells Out in Hours

H&M's collaboration with Korean designer brand Rokh...

215 Doctors Under Investigation: How Loan Fraud in Hospital Startups Exploded to 130 Billion Won

Police investigate 215 doctors for fraud involving inflated bank balances to secure $975 million in loans for hospitals.

Iran’s Mehdi Torabi Secures Visa: Will He Shine in 2026 FIFA World Cup?

Mehdi Torabi's visa issues are resolved, allowing him to participate in FIFA World Cup qualifiers in North America.

Tag: Keytruda

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion’s CT-P51: Will This Keytruda Biosimilar Disrupt the 44 Billion USD Cancer Drug Market?

Celltrion has applied for approval of its biosimilar CT-P51 for the global blockbuster immuno-oncology drug Keytruda (pembrolizumab).

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.